Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer-Reference-Cited by-同舟云学术

Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer

Published:2021-07 Issue: Volume:29 Page:40-46
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Houben Jeroen,McColl Gill,HAM Kaanders Johannes,Smeenk Robert J.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference30 articles.

1. Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer;Kalbasi;JAMA Oncol,2015

2. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy;Peeters;J Clin Oncol,2006

3. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage;Heemsbergen;Int J Radiat Oncol Biol Phys,2006

4. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients;Zelefsky;Int J Radiat Oncol Biol Phys,2002

5. Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control;De Meerleer;Radiother Oncol,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implementation of real time motion management for prostate SBRT: A radiation therapist’s perspective;Technical Innovations & Patient Support in Radiation Oncology;2024-09

2. Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study;Radiation Oncology;2023-01-02

3. A dose escalated fiducial marker-based image guided radical radiotherapy in locally advanced prostate cancers: A single institute experience from India;Journal of Cancer Research and Therapeutics;2023

4. A Comparison between Patient- and Physician-Reported Late Radiation Toxicity in Long-Term Prostate Cancer Survivors;Cancers;2022-03-25

5. Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016);European Urology Oncology;2021-12